BiotechTube
BCN Peptides

BCN Peptides

Barcelona, Spain· Est.
bcnpeptides.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

BCN Peptides is a privately-owned, Barcelona-based Contract Development and Manufacturing Organization (CDMO) focused exclusively on the GMP manufacture of peptides. Founded in 2008, it operates across four core business lines: generic peptides, new chemical entities (NCEs), NeoAntigen peptides for personalized medicine, and cosmetic peptides. The company serves global pharmaceutical markets, is audited by major regulatory bodies like the FDA and EDQM, and positions itself as a customer-oriented partner for peptide drug development from preclinical to commercial stages.

OncologyMetabolic DisordersCosmetic/DermatologyVeterinary

Technology Platform

GMP peptide synthesis, purification, and analytical platform for generic, novel, and personalized (NeoAntigen) peptides, serving pharmaceutical, veterinary, and cosmetic applications.

Funding History

1
GrantUndisclosed

Opportunities

The growing global peptide therapeutics market and the biopharma industry's trend towards outsourcing manufacturing present a significant expansion opportunity.
Specialization in high-value niches like GMP NeoAntigen production for personalized cancer immunotherapy positions the company at the forefront of a cutting-edge therapeutic area.

Risk Factors

Revenue is dependent on client pipelines and subject to client concentration risk.
Maintaining stringent GMP compliance across multiple regulatory jurisdictions is operationally critical and costly.
The company faces intense competition from larger CDMOs and other peptide specialists, which could pressure pricing and margins.

Competitive Landscape

BCN Peptides competes in the peptide CDMO space against larger, diversified CDMOs (e.g., Lonza, Bachem, PolyPeptide) and other specialized peptide manufacturers. Its differentiation lies in its pure-play peptide focus, deep regulatory expertise in Europe, and specialized capabilities in NeoAntigen production. Competition is based on technical capability, quality, regulatory track record, price, and customer service.

More companies in Biologics / Biosimilars →More companies in Spain →